相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States
Anirban Basu
HEALTH AFFAIRS (2020)
A strategic approach to COVID-19 vaccine R&D
Lawrence Corey et al.
SCIENCE (2020)
Postmarketing Safety of Vaccines Approved by the US Food and Drug Administration A Cohort Study
Noam Tau et al.
ANNALS OF INTERNAL MEDICINE (2020)
A Contemporary Review of Neurological Sequelae of COVID-19
Brian Fiani et al.
FRONTIERS IN NEUROLOGY (2020)
Developing a SARS-CoV-2 Vaccine at Warp Speed
Kevin P. O'Callaghan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cardiac sequelae of novel coronavirus disease 2019 (COVID-19): a clinical case series
Zachary D. Demertzis et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2020)
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
Vaccines and global health: In search of a sustainable model for vaccine development and delivery
Rino Rappuoli et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Contribution of NIH funding to new drug approvals 2010-2016
Ekaterina Galkina Cleary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus
Jianping Li et al.
PLOS ONE (2018)
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
Dimitrios Gouglas et al.
LANCET GLOBAL HEALTH (2018)
Timelines of translational science: From technology initiation to FDA approval
Laura M. McNamee et al.
PLOS ONE (2017)
Vaccines for epidemic infections and the role of CEPI
Stanley A. Plotkin
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
As Technologies for Nucleotide Therapeutics Mature, Products Emerge
Jennifer M. Beierlein et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities
Jennifer M. Beierlein et al.
CLINICAL THERAPEUTICS (2017)
Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies
F. D. Ledley et al.
GENE THERAPY (2014)
Vaccine R&D: Past performance is no guide to the future
Peter Stephens
VACCINE (2014)
Risk in Vaccine Research and Development Quantified
Esther S. Pronker et al.
PLOS ONE (2013)
Patterns of technological innovation in biotech
Laura M. McNamee et al.
NATURE BIOTECHNOLOGY (2012)
Developing mRNA-vaccine technologies
Thomas Schlake et al.
RNA BIOLOGY (2012)
Metrics associated with NIH funding: a high-level view
Kevin W. Boyack et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2011)
Successes and failures: Worldwide vaccine development and application
Donald P. Francis
BIOLOGICALS (2010)
EXPLORING THE LIMITS OF THE TECHNOLOGY S-CURVE. PART I: COMPONENT TECHNOLOGIES
CLAYTON M. CHRISTENSEN
PRODUCTION AND OPERATIONS MANAGEMENT (2010)
Lock in, the state and vaccine development: Lessons from the history of the polio vaccines
SS Blume
RESEARCH POLICY (2005)
分享论文
